New benchmark confirms LENSai’s ability to accurately predict binding on 17 previously unseen antibody-antigen complexes, achieving near-crystallography precision without prior training data. AUSTIN, Texas–(BUSINESS WIRE)–$IPA #AI–ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), an AI-powered biotherapeutics company, today announced a new validation study supporting the generalizability of its proprietary epitope mapping platform, LENSai, powered … [Read more…]

WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the Compensation Committee of the company’s Board of Directors, made up entirely of independent directors, approved the grant of non-qualified stock options to purchase an aggregate of 175,000 … [Read more…]

BAAR, Switzerland & OSAKA, Japan & TOKYO–(BUSINESS WIRE)–Stallergenes Greer, Shionogi & Co., Ltd. (“Shionogi”) and CEOLIA Pharma Co. Ltd (“CEOLIA”) today announced the transition of promotional activities for Actair® in Japan. Actair® is Stallergenes Greer’s sublingual immunotherapy tablet for the treatment of patients suffering from house dust mite induced allergic rhinitis. After ending the license … [Read more…]

Reflects the Company’s strategic focus on commercializing non-therapeutic proteins and unlocking long-term value from its C1 and Dapibus™ gene expression platforms JUPITER, Fla.–(BUSINESS WIRE)–$DYAI #BioSolutions–Dyadic International, Inc. (“Dyadic”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered input proteins for non-therapeutic applications in life sciences, food and nutrition, and … [Read more…]

Virginia Cardinal Care beneficiaries are now able to choose Humana Healthy Horizons for their health care coverage LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Healthy Horizons is now a Medicaid plan option for Virginians covered by Virginia Cardinal Care. “At Humana, we put our members’ health first, and we are committed to improving the holistic well-being of the communities … [Read more…]

Leveraging Unite Us’ closed-loop referral system, the CONNECT initiative expands to Rio Arriba to enhance coordinated care and address the impact of the Opioid crisis. ESPAÑOLA, N.M.–(BUSINESS WIRE)–#Communityhealth–Rio Arriba County is taking a significant step forward in addressing the impact of the opioid crisis with the launch of Rio Arriba CONNECT. The local program, powered … [Read more…]

PLANTATION, Fla.–(BUSINESS WIRE)–#DollarGeneral—NationsBenefits®, the leading supplemental benefits and healthcare fintech solutions provider, is proud to announce a new partnership with Dollar General, the largest discount retailer in the United States by store count. By integrating with Dollar General at more than 20,000 locations across the nation, the NationsBenefits’ proprietary Basket Analyzer Service (BAS) will provide … [Read more…]

Data presented today at the ESHRE congress builds evidence for conventional-based Follicular Stimulating Hormone (FSH) dosing for Rekovelle® (follitropin delta); alongside its existing unique algorithm-based dosing   PARIS–(BUSINESS WIRE)–Follitropin delta starting dose of 15 micrograms (µg)/day has comparable efficacy and safety as a starting dose of 225 International Units (IU)/day of follitropin alfa for ovarian … [Read more…]

DALLAS–(BUSINESS WIRE)–MediaPSC proudly announces the debut of TBH Breast Implants, a first-of-its-kind, monthly digital talk show series set to premiere July 9, 2025. Hosted by internationally recognized plastic surgeons Drs. William P. Adams Jr. and Rod Rohrich, this innovative program will bring unfiltered, evidence-based conversations to the forefront of the breast implant conversation—uniting top-tier clinicians, … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–$REVB #AKI—Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), announced today that, on July 7, 2025, the Company will implement a 1-for-3 reverse split of its common stock following approval at its Special Meeting of Stockholders held on June 23, 2025. The reverse stock split will be effective as of the morning … [Read more…]